These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32420702)

  • 1. Risk of malformation after ondansetron in pregnancy: An updated systematic review and meta-analysis.
    Picot C; Berard A; Grenet G; Ripoche E; Cucherat M; Cottin J
    Birth Defects Res; 2020 Aug; 112(13):996-1013. PubMed ID: 32420702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring.
    Huybrechts KF; Hernández-Díaz S; Straub L; Gray KJ; Zhu Y; Patorno E; Desai RJ; Mogun H; Bateman BT
    JAMA; 2018 Dec; 320(23):2429-2437. PubMed ID: 30561479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Ondansetron in Pregnancy and Risk of Congenital Malformations.
    Huybrechts KF; Hernandez-Diaz S; Straub L; Gray KJ; Zhu Y; Mogun H; Bateman BT
    JAMA; 2020 Jan; 323(4):372-374. PubMed ID: 31730152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nausea and vomiting in pregnancy: A place for ondansetron?].
    Coulm B
    Gynecol Obstet Fertil Senol; 2021 Dec; 49(12):947-950. PubMed ID: 34700033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects.
    Parker SE; Van Bennekom C; Anderka M; Mitchell AA;
    Obstet Gynecol; 2018 Aug; 132(2):385-394. PubMed ID: 29995744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC).
    Damkier P; Kaplan YC; Shechtman S; Diav-Citrin O; Cassina M; Weber-Schoendorfer C
    Basic Clin Pharmacol Toxicol; 2021 Apr; 128(4):579-582. PubMed ID: 33275828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester ondansetron exposure and risk of structural birth defects.
    Zambelli-Weiner A; Via C; Yuen M; Weiner DJ; Kirby RS
    Reprod Toxicol; 2019 Jan; 83():14-20. PubMed ID: 30385129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major Congenital Malformation Risk After First Trimester Gestational Exposure to Oral or Intravenous Ondansetron.
    Andrade C
    J Clin Psychiatry; 2020 Jun; 81(3):. PubMed ID: 32526103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron Use in Pregnancy and Birth Defects: A Systematic Review.
    Carstairs SD
    Obstet Gynecol; 2016 May; 127(5):878-883. PubMed ID: 27054939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of ondansetron during pregnancy and the risk of major congenital malformations: A systematic review and meta-analysis.
    Kaplan YC; Richardson JL; Keskin-Arslan E; Erol-Coskun H; Kennedy D
    Reprod Toxicol; 2019 Jun; 86():1-13. PubMed ID: 30849498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.
    Anderka M; Mitchell AA; Louik C; Werler MM; Hernández-Diaz S; Rasmussen SA;
    Birth Defects Res A Clin Mol Teratol; 2012 Jan; 94(1):22-30. PubMed ID: 22102545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies.
    Dolovich LR; Addis A; Vaillancourt JM; Power JD; Koren G; Einarson TR
    BMJ; 1998 Sep; 317(7162):839-43. PubMed ID: 9748174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of ondansetron during pregnancy and congenital malformations in the infant.
    Danielsson B; Wikner BN; Källén B
    Reprod Toxicol; 2014 Dec; 50():134-7. PubMed ID: 25450422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New evidence for concern over the risk of birth defects from medications for nausea and vomitting of pregnancy.
    Bérard A; Sheehy O; Gorgui J; Zhao JP; Soares de Moura C; Bernatsky S
    J Clin Epidemiol; 2019 Dec; 116():39-48. PubMed ID: 31352006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ondansetron in Pregnancy and the Risk of Congenital Malformations: A Systematic Review.
    Lavecchia M; Chari R; Campbell S; Ross S
    J Obstet Gynaecol Can; 2018 Jul; 40(7):910-918. PubMed ID: 29754832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort.
    Dormuth CR; Winquist B; Fisher A; Wu F; Reynier P; Suissa S; Dahl M; Ma Z; Lu X; Zhang J; Raymond CB; Filion KB; Platt RW; Moriello C; Paterson JM;
    JAMA Netw Open; 2021 Apr; 4(4):e215329. PubMed ID: 33890993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
    Bérard A; Iessa N; Chaabane S; Muanda FT; Boukhris T; Zhao JP
    Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ondansetron use in the first trimester of pregnancy and the risk of neonatal ventricular septal defect.
    Lemon LS; Bodnar LM; Garrard W; Venkataramanan R; Platt RW; Marroquin OC; Caritis SN
    Int J Epidemiol; 2020 Apr; 49(2):648-656. PubMed ID: 31860078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis.
    Yakoob MY; Bateman BT; Ho E; Hernandez-Diaz S; Franklin JM; Goodman JE; Hoban RA
    Hypertension; 2013 Aug; 62(2):375-81. PubMed ID: 23753416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam.
    Safra MJ; Oakley GP
    Lancet; 1975 Sep; 2(7933):478-80. PubMed ID: 51287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.